Airway pressure release ventilation and pediatrics: theory and practice

Critical Care Nursing Clinics of North America
P M Frawley, Nader Habashi

Abstract

Airway pressure release ventilation (APRV) facilitates oxygenation and ventilation by maintaining an elevated baseline airway pressure similar to continuous positive airway pressure (CPAP). APRV differs from CPAP only by the addition of regular, brief release of airway pressure to facilitate carbon dioxide removal. The baseline pressure maintains a near continuous airway pressure to facilitate recruitment, improving ventilation and oxygenation. Pediatric patients who have recruitable lung disease may be well suited to the application of APRV.

References

Jan 5, 1978·The New England Journal of Medicine·P B TerryH A Menkes
Sep 1, 1992·Critical Care Medicine·S K FalkenhainJ S Gregory
Mar 1, 1991·Critical Care Medicine·L D MartinA L Bilenki
Oct 1, 1988·Chest·W GarnerJ Räsänen
Dec 1, 1988·Critical Care Medicine·I T JouselaJ Tahvanainen
Sep 1, 1974·Anesthesiology·A B Froese, A C Bryan
Jan 1, 1974·Thorax·A Hislop, L Reid
Jun 17, 1971·The New England Journal of Medicine·G A GregoryW K Hamilton
Jul 1, 1981·The Journal of Pediatrics·T A CiszekP Nelson
Aug 1, 1982·Thorax·W M Thurlbeck
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·L GattinoniF Valenza
Jul 1, 1994·American Journal of Respiratory and Critical Care Medicine·W J LammR K Albert
Mar 1, 1994·Critical Care Medicine·L D Martin, R C Wetzel
Mar 1, 1996·American Journal of Respiratory and Critical Care Medicine·G CinnellaL Brochard
Feb 1, 1997·Intensive Care Medicine·D F Willson, J H Jiao
Jan 28, 1998·American Journal of Respiratory and Critical Care Medicine·D Dreyfuss, G Saumon
Aug 26, 1998·Heart & Lung : the Journal of Critical Care·Y HarelB J Evans
Aug 26, 1999·Seminars in Pediatric Surgery·R B Hirschl
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
Jul 4, 2001·American Journal of Respiratory and Critical Care Medicine·C PutensenN Mutz
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·L GattinoniL R Goodman
Jan 5, 2002·AACN Clinical Issues·P M Frawley, N M Habashi
May 7, 2002·American Journal of Respiratory and Critical Care Medicine·Gabriella de DuranteV Marco Ranieri
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Peter Q EichackerCharles Natanson
Mar 12, 2003·Chest·Michael R Littner
May 10, 2003·American Journal of Respiratory and Critical Care Medicine·Jean-Damien Ricard
Jun 10, 2003·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·T R SchultzM Helfaer

❮ Previous
Next ❯

Citations

Jul 12, 2011·Critical Care Clinics·Adrian A Maung, Lewis J Kaplan
Apr 10, 2010·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·Louise Rose
Aug 10, 2010·Paediatric Respiratory Reviews·Jonathan Egan
Nov 30, 2006·Pediatric Pulmonology·Jambunathan Krishnan, Wynne Morrison
Jul 16, 2010·Journal of Advanced Nursing·Ju-Eun SongChung-Mo Nam
Nov 5, 2008·AACN Advanced Critical Care·Suzanne M Burns
Jan 31, 2015·Journal of Applied Physiology·Bradford J SmithJason H T Bates
Apr 24, 2013·The Journal of Trauma and Acute Care Surgery·Adrian A MaungKimberly A Davis
Sep 29, 2012·The Journal of Trauma and Acute Care Surgery·Adrian A MaungKimberly A Davis
Sep 27, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Esmond L ArrindellRandal K Buddington
Apr 3, 2009·Critical Care Nurse·Caroline C Broden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.